PMC5080471_01
Platelet trend perisplenectomy and associated interventions. Patient received last dose of romiplostim eight days prior to surgery. At peak platelet levels, patient was symptomatic, prompting intervention with plateletpheresis.
CRIHEM2016-5403612.001.jpg
PMC5080471_01_CRIHEM2016-5403612.001.jpg
fig1
Postoperatively, the patient was noted to develop thrombocytosis, beginning on postoperative day 1 and continuing until the day of discharge on postoperative day 5 (Figure 1).